Dan Dearen is a Independent Board Member and Chair of Audit Committee at Beta Bionics. He possess expertise in strategy, start ups, mergers and acquisitions, strategic planning, business development and 35 more skills. Colleagues describe him as "I have known Dan for over 20 years and most recently consulted for him at Vessix. Dan is very good at simplifying complex business situations – this enables him to identify the important objectives for a company and focus on those key goals. He is expert in finance, business development and company operations and consistently approaches interactions with a positive outlook, making it a pleasure to work with him. Dan was a key player in redirecting Vessix from a focus on peripheral artery disease to hypertension. This change in direction, some good decisions and very hard work led to Boston Scientific’s acquisition of Vessix. Dan is a great leader, a clear thinker and an honorable person." and "Dan is a top-tier C-level executive. I have had the benefit of working with Dan both as a partner at an investment bank and as a lawyer (with his company as a client). When you work with Dan you learn. Dan is not only an excellent leader, but he makes those around him better. He has an incredible ability to read a complex business situation, understand it and deliver a strategy leading to sucess. In addition to all of that he is a pleasure to work with. Everyone I know who has worked with him or for him has benefited greatly."